Fifth Third Bancorp’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Fifth Third Bancorp’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$446	Hold	150	–	–	﹤0.01%	4241
2026 Q1	$465	Hold	150	–	–	﹤0.01%	4190
2025 Q4	$600	Hold	150	–	–	﹤0.01%	2542
2025 Q3	$1.86K	Hold	150	–	–	﹤0.01%	2461
2025 Q2	$3.15K	Hold	150	–	–	﹤0.01%	2289
2025 Q1	$4.44K	Hold	150	–	–	﹤0.01%	2211
2024 Q4	$4.88K	Hold	150	–	–	﹤0.01%	2171
2024 Q3	$6.03K	Hold	150	–	–	﹤0.01%	2139
2024 Q2	$7.74K	Hold	150	–	–	﹤0.01%	2002
2024 Q1	$6.66K	Hold	150	–	–	﹤0.01%	1990
2023 Q4	$6.6K	Hold	150	–	–	﹤0.01%	2101
2023 Q3	$7.95K	Hold	150	–	–	﹤0.01%	2036
2023 Q2	$9.21K	Hold	150	–	–	﹤0.01%	2004
2023 Q1	$6.87K	Hold	150	–	–	﹤0.01%	2228
2022 Q4	$18.4K	Hold	150	–	–	﹤0.01%	1737
2022 Q3	$23K	Hold	150	–	–	﹤0.01%	1636
2022 Q2	$28K	Hold	150	–	–	﹤0.01%	1592
2022 Q1	$37K	Hold	150	–	–	﹤0.01%	1568
2021 Q4	$39K	Hold	150	–	–	﹤0.01%	1616
2021 Q3	$50K	Buy	+150	New	+$59K	﹤0.01%	1452

Other funds holding CANF

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Fifth Third Bancorp's CANF Position: Q2 2026 in Review

Fifth Third Bancorp held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q2 2026 at 150 shares worth $446. The position accounts for ﹤0.01% of the portfolio, ranked #4241.

Fifth Third Bancorp first reported a position in CANF in Q3 2021 and has held it in 20 quarters since. The position peaked at $50K in Q3 2021. 4 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

Fifth Third Bancorp held 150 shares of Can-Fite BioPharma American Depositary Shares worth $446 as of Q2 2026.
Fifth Third Bancorp left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q2 2026.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4241 holding.
Fifth Third Bancorp first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2021 and has held it in 20 quarters since.
Fifth Third Bancorp's Can-Fite BioPharma American Depositary Shares position peaked at $50K in Q3 2021.
4 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.